Otros idiomas Nang Kuang Pharmaceutical Co., Ltd.

Acciones

1752

TW0001752004

Precio de cierre Taiwan S.E. Otros sitios de cotización 00:00:00 10/05/2024			Varia. Cinco días.	Varia. 1 de enero.
45,45 ^TWD	+1,56 %		+1,91 %	-14,73 %

08/05	Nang Kuang Pharmaceutical Co. presenta los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
26/03	Nang Kuang Pharmaceutical Co. Ltd. presenta los resultados del ejercicio finalizado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	26/03
Nang Kuang Pharmaceutical Co., Ltd. Announces Changes in Chief Internal Auditor	12/03
Nang Kuang Pharmaceutical Co., Ltd. Appoints Pen-Sung Chen as Corporate Governance Officer	08/03
Nang Kuang Pharmaceutical Co., Ltd. Announces Resignation of Wen-Yung Tsai as Spokesperson, Financial Officer, Accounting Officer and Corporate Governance Officer	07/02
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	02/11
Nang Kuang Pharmaceutical Co., Ltd.(TWSE:1752) added to S&P Global BMI Index	18/09/23
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/08/23
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	06/03/23
Nang Kuang Pharmaceutical Co., Ltd. Appoints Wen-Yung Tsai as Corporate Governance Officer	04/11/22
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	04/11/22
Nang Kuang Pharmaceutical : Announcement of the consolidated financial report for the 2nd quarter of 2022 approved by the board of directors	03/08/22
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	03/08/22
Nang Kuang Pharmaceutical : has received final U.S.FDA approval for its ANDA.	26/05/22
Nang Kuang Pharmaceutical Co., Ltd. Receives Final U.S. FDA Approval for Its ANDA	26/05/22
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	04/05/22
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	02/03/22
Nang Kuang Pharmaceutical Co., Ltd.(TWSE:1752) added to Taiwan TAIEX Index	17/02/22
Nang Kuang Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	05/11/21

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Nang Kuang Pharmaceutical Co., Ltd.

Acciones

1752

TW0001752004

Otros idiomas

Filtros